Immunoassay Development, Method Validation and Bioanalysis

We have the longest track record of ultra sensitive immunoassays in the industry

Chimera Biotec provides ultra sensitive GLP/GCP bioanalytical support for all phases of drug development and non-regulated rapid discovery phase research. Building upon our proprietary Immuno-PCR technology, ImperacerĀ®, our scientific team has gained vast experience in the development and validation of ultra sensitive immunoassays. Starting with our custom assay development or assay transfer on your preferred platform, take advantage of our strong scientific background and technical services - conducted under the strict quality regime of your choice.

For more than 20 years, Chimera Biotec has specialized in supporting drug development programs with highest demands on bioanalytical quality. Our long standing know how in beyond ELISA sensitive immunoassays enables us to make the most out of any immunoassay platform.